ArticlePloS one2025
Analysis of arrhythmia and its risk factors in patients with COVID-19.
Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTo investigate the incidence of arrhythmia in patients with coronavirus disease 2019 (COVID-19) and analyze its risk factors.
methodsThis was a retrospective cross-sectional study that surveyed 324 COVID-19 patients admitted to the Second Hospital of Shanxi Medical University from 2020 to 2022. General data, vital signs, myocardial enzyme and imaging data of the patients were collected. The characteristics of COVID-19 patients with arrhythmia were analysed, and multivariate logistic regression was used to analyze the risk factors for arrhythmia in patients. The receiver operating characteristic (ROC) curve was plotted to evaluate the efficacy of the regression equation in predicting arrhythmia in COVID-19 patients.
resultsCompared with COVID-19 patients without arrhythmia, those with arrhythmia were found to have significant differences in heart rate, prothrombin time (PT), activated partial thromboplastin time (APTT), blood glucose, uric acid, serum potassium, serum total cholesterol, high-sensitivity troponin I (hs-TnI), N-terminal pro B-type natriuretic peptide (NT-proBNP), aortic root diameter, left atrial diameter (LAD), left ventricular end-diastolic diameter (LVEDD), left ventricular ejection fraction (LVEF), fractional shortening (FS), end-systolic volume (ESV), and diabetes (all P < 0.05). Multivariate logistic regression analysis revealed that heart rate, PT, hs-TnI, ESV, serum potassium, blood glucose and diabetes were risk factors for arrhythmia in COVID-19 patients (all P < 0.05). ROC curve analysis showed that the area under the curve (AUC) was 0.773 (95%CI: 0.711-0.834, P < 0.001).
conclusionHeart rate, PT, hs-TnI, ESV, serum potassium, blood glucose and diabetes are risk factors for arrhythmia in COVID-19 patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.